BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22513175)

  • 1. Anti-M(3) peptide IgG from Sjögren's syndrome triggers apoptosis in A253 cells.
    Reina S; Sterin-Borda L; Borda E
    Cell Immunol; 2012; 275(1-2):33-41. PubMed ID: 22513175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands.
    Reina S; Sterin-Borda L; Passafaro D; Borda E
    Arch Oral Biol; 2011 May; 56(5):413-20. PubMed ID: 21371688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253.
    Sisto M; Lisi S; Castellana D; Scagliusi P; D'Amore M; Caprio S; Scagliusi A; Acquafredda A; Panaro MA; Mitolo V
    J Autoimmun; 2006 Aug; 27(1):38-49. PubMed ID: 16797160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
    Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
    Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications.
    Reina S; Sterin-Borda L; Orman B; Borda E
    J Neuroimmunol; 2004 May; 150(1-2):107-15. PubMed ID: 15081254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siögren's syndrome: anti-Ro and anti-La autoantibodies trigger apoptotic mechanism in the human salivary gland cell line, A-253.
    Lisi S; Sisto M; Scagliusi P; Mitolo V; D'Amore M
    Panminerva Med; 2007 Sep; 49(3):103-8. PubMed ID: 17912146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.
    Bacman S; Perez Leiros C; Sterin-Borda L; Hubscher O; Arana R; Borda E
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):151-6. PubMed ID: 9430556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of anti-M₃muscarinic acetylcholine receptor IgG of primary Sjögren's syndrome on the enzymatic antioxidant system in rat submandibular gland.
    Reina S; Rodríguez M; Stranieri G; Borda E
    J Oral Pathol Med; 2015 Nov; 44(10):876-83. PubMed ID: 25726719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E; Lee SW; Kim N; Choi Y; Park K
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
    Bacman S; Berra A; Sterin-Borda L; Borda E
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):321-7. PubMed ID: 11157861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
    Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
    Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.
    Passafaro D; Reina S; Sterin-Borda L; Borda E
    Eur J Oral Sci; 2010 Apr; 118(2):131-8. PubMed ID: 20487001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253.
    Lisi S; Sisto M; Soleti R; Saponaro C; Scagliusi P; D'Amore M; Saccia M; Maffione AB; Mitolo V
    J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
    Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
    Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
    Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
    Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
    J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors.
    Bacman SR; Berra A; Sterin-Borda L; Borda ES
    Curr Eye Res; 1998 Dec; 17(12):1135-42. PubMed ID: 9872535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
    Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
    Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.